BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), announces that its Board of Directors has adopted a shareholder rights plan designed to encourage the fair treatment of shareholders in connection with any take-over offer for the Corporation. The plan was not adopted in response to an anticipated takeover bid, but as a general planning measure.
